Market by Source, Product, Application, and Country Outlook | Forecast 2022-2028
As stated in Triton Market
Research’s report, the medical collagen market in Europe is anticipated to
garner revenue at a CAGR of 6.87%
over the forecasting years 2022 to 2028.
Report scope can be customized per your requirements. Request For Customization
The
countries assessed in the region comprise:
•
The United Kingdom
•
Germany
•
France
•
Spain
•
Italy
•
Rest of Europe
Germany
captures the highest market share in the region. Europe is among the most developed regions,
with the population investing heavily in their health. Over the years, the
region’s geriatric population has grown substantially, increasing the demand
for enhanced healthcare services. Moreover, the high number of the older
population has led to a rise in various health concerns. This has majorly
supported the demand for collagen supplements. Collagen supplements help
enhance skin and solve various medical issues. Therefore, these factors are
expected to widen the scope and growth of the medical collagen market across
the region.
People often consume gelatine products with
their daily meals in Germany. The growing awareness about the benefits of
consuming collagen has majorly boosted the market’s growth. Moreover, the rise
in awareness has encouraged prominent companies to manufacture gelatine-based
products. Furthermore, products like collagen powder and gelatin-based capsules
are largely marketed in the country. Thus, these factors are anticipated to
fuel the German medical collagen market’s development.
On the other hand, collagen is widely included
in drinks and dietary foods in the UK. Since collage is rich in protein,
consumers are heavily incorporating collagen in their diet to treat various
conditions. Gelatine is often included in dietary food, including capsules.
Hence, the benefits offered by collagen majorly drive the medical collagen
market’s progress across the United Kingdom.
Collagen plays a crucial role in the process of
wound healing, as it is rich in protein. In this regard, it attracts
fibroblasts and stimulates the deposition of new collagen. Moreover, collagen
dressing is primary for chronic wounds. The collagen used in this process is
derived from bovine, porcine, and avian collagen. The medical collagen market’s growth is assessed based on application,
source, and product. The application segment is branched into hemostats,
vascular grafts, wound care, diagnostics, tissue scaffolds, bone grafts,
cartilage repair, and other applications.
The
major firms in the given market include Nitta Gelatin Inc, Darling Ingredients
Inc, Lapi Gelatine, Gelita, Collagen Matrix Inc, Integra Life Sciences, and
Stryker.
Gelita is among the leading players engaged in
manufacturing and supplying collagen-based products. It serves various
industries, including food, health, and pharmaceutical. The company’s product
line includes Peptiplus, a protein source providing nutrients through beverages
and supplements. According to company reports, it holds a significant
percentage of share in the medical collagen market. With operations across
multiple regions, Gelita is headquartered in Eberbach, Germany.
Key deliverables of the report:
●
Market CAGR during the forecasting years 2022-2028
●
Detailed data highlighting key insights, industry components, and
market strategies
● Comprehensive information and estimation of the medical collagen
market revenue growth in Europe and its influence on the parent market
●
In-depth study of forthcoming trends in consumer behavioral
patterns
●
A meticulous analysis of the competitive landscape, vendor
scorecard, and Porter’s Five Forces
● A wide-ranging study of factors that will challenge the EU medical
collagen software market’s growth during the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
1. EUROPE
MEDICAL COLLAGEN MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE MEDICAL COLLAGEN INDUSTRY
2.2. KEY
INSIGHTS
2.2.1. SIGNIFICANT
INVESTMENT IN RESEARCH AND DEVELOPMENT ACTIVITIES
2.2.2. EVOLVING
HEALTHCARE INDUSTRY
2.2.3. LAUNCH
OF NEW PRODUCTS DUE TO INCREASED RESEARCH
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
IMPACT ANALYSIS
2.4.1. QUALITY
2.4.2. SIDE-EFFECTS
2.4.3. PRODUCT
EFFECTIVENESS
2.4.4. PRICE
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.8. REGULATORY
FRAMEWORK
2.9. KEY
MARKET STRATEGIES
2.9.1. ACQUISITIONS
2.9.2. PRODUCT
LAUNCHES
2.9.3. PARTNERSHIPS
2.9.4. BUSINESS
EXPANSIONS
2.10. MARKET
DRIVERS
2.10.1. INCREASING
DEMAND FROM THE MEDICAL DEVICES INDUSTRY
2.10.2. GROWING
PUBLIC AWARENESS
2.11. MARKET
CHALLENGES
2.11.1. HEALTH-RELATED
ISSUES
2.11.2. CONSUMERS
LIMITING THE USE OF ANIMAL-BASED PRODUCTS
2.12. MARKET
OPPORTUNITIES
2.12.1. GROWTH
OF THE COSMETICS INDUSTRY
2.12.2. RISING
DEMAND FOR COLLAGEN-RICH FOOD & BEVERAGES
3. EUROPE
MEDICAL COLLAGEN MARKET OUTLOOK – BY SOURCE
3.1. BOVINE
3.2. PORCINE
3.3. OTHER
SOURCES
4. EUROPE
MEDICAL COLLAGEN MARKET OUTLOOK – BY PRODUCT
4.1. GELATINE
4.2. HYDROLYZED
COLLAGEN
4.3. NATIVE
COLLAGEN
4.4. OTHER
PRODUCTS
5. EUROPE
MEDICAL COLLAGEN MARKET OUTLOOK – BY APPLICATION
5.1. WOUND
CARE
5.2. BONE
GRAFTS
5.3. TISSUE
SCAFFOLDS
5.4. CARTILAGE
REPAIR
5.5. HEMOSTATS
5.6. DIAGNOSTICS
5.7. VASCULAR
GRAFTS
5.8. OTHER
APPLICATIONS
6. EUROPE
MEDICAL COLLAGEN MARKET – COUNTRY OUTLOOK
6.1. THE
UNITED KINGDOM
6.2. GERMANY
6.3. FRANCE
6.4. SPAIN
6.5. ITALY
6.6. REST
OF EUROPE
7. COMPETITIVE
LANDSCAPE
7.1. GELITA
7.2. NITTA
GELATIN INC
7.3. NIPPI
INC
7.4. ITALGEL
7.5. WEISHARDT
7.6. DARLING
INGREDIENTS INC
7.7. LAPI
GELATINE
7.8. TESSENDERLO
GROUP
7.9. DSM
7.10. COLLAGEN
MATRIX INC
7.11. CONNOILS
LLC
7.12. INTEGRA
LIFE SCIENCES
7.13. SYMATESE
7.14. STRYKER
7.15. JELLAGEN
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: EUROPE MEDICAL
COLLAGEN MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR
SCORECARD
TABLE 3: REGULATORY
FRAMEWORK
TABLE 4: LIST OF
ACQUISITIONS
TABLE 5: LIST OF
PRODUCT LAUNCHES
TABLE 6: LIST OF
PARTNERSHIPS
TABLE 7: LIST OF
BUSINESS EXPANSIONS
TABLE 8: EUROPE MEDICAL
COLLAGEN MARKET, BY SOURCE, 2022-2028 (IN $ MILLION)
TABLE 9: EUROPE MEDICAL
COLLAGEN MARKET, BY PRODUCT, 2022-2028 (IN $ MILLION)
TABLE 10: EUROPE
MEDICAL COLLAGEN MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 11: EUROPE
MEDICAL COLLAGEN MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
FIGURE 1: KEY BUYING
IMPACT ANALYSIS
FIGURE 2: MARKET
ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY
COMPONENTS
FIGURE 4: EUROPE
MEDICAL COLLAGEN MARKET, BY SOURCE, 2021 & 2028 (IN %)
FIGURE 5: EUROPE
MEDICAL COLLAGEN MARKET, BY BOVINE, 2022-2028 (IN $ MILLION)
FIGURE 6: EUROPE
MEDICAL COLLAGEN MARKET, BY PORCINE, 2022-2028 (IN $ MILLION)
FIGURE 7: EUROPE
MEDICAL COLLAGEN MARKET, BY OTHER SOURCES, 2022-2028 (IN $ MILLION)
FIGURE 8: EUROPE
MEDICAL COLLAGEN MARKET, BY PRODUCT, 2021 & 2028 (IN %)
FIGURE 9: EUROPE
MEDICAL COLLAGEN MARKET, BY GELATINE, 2022-2028 (IN $ MILLION)
FIGURE 10: EUROPE
MEDICAL COLLAGEN MARKET, BY HYDROLYZED COLLAGEN, 2022-2028 (IN $ MILLION)
FIGURE 11: EUROPE
MEDICAL COLLAGEN MARKET, BY NATIVE COLLAGEN, 2022-2028 (IN $ MILLION)
FIGURE 12: EUROPE
MEDICAL COLLAGEN MARKET, BY OTHER PRODUCTS, 2022-2028 (IN $ MILLION)
FIGURE 13: EUROPE
MEDICAL COLLAGEN MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 14: EUROPE
MEDICAL COLLAGEN MARKET, BY WOUND CARE, 2022-2028 (IN $ MILLION)
FIGURE 15: EUROPE
MEDICAL COLLAGEN MARKET, BY BONE GRAFTS, 2022-2028 (IN $ MILLION)
FIGURE 16: EUROPE
MEDICAL COLLAGEN MARKET, BY TISSUE SCAFFOLDS, 2022-2028 (IN $ MILLION)
FIGURE 17: EUROPE
MEDICAL COLLAGEN MARKET, BY CARTILAGE REPAIR, 2022-2028 (IN $ MILLION)
FIGURE 18: EUROPE
MEDICAL COLLAGEN MARKET, BY HEMOSTATS, 2022-2028 (IN $ MILLION)
FIGURE 19: EUROPE
MEDICAL COLLAGEN MARKET, BY DIAGNOSTICS, 2022-2028 (IN $ MILLION)
FIGURE 20: EUROPE
MEDICAL COLLAGEN MARKET, BY VASCULAR GRAFTS, 2022-2028 (IN $ MILLION)
FIGURE 21: EUROPE
MEDICAL COLLAGEN MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)
FIGURE 22: EUROPE
MEDICAL COLLAGEN MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 23: THE UNITED
KINGDOM MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: GERMANY
MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: FRANCE
MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: SPAIN
MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)
FIGURE 27: ITALY
MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)
FIGURE 28: REST OF
EUROPE MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)